Isabella Capodanno

The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.

Andrea Gallamini, Luigi Rigacci, Francesco Merli et al. · PubMed · 2006 · 294 citations

Medicine, Nuclear Medicine, Oncology +16

Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi

Francesco Merli, Stefano Luminari, Fiorella Ilariucci et al. · British Journal of Haematology · 2011 · 133 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study

Simona Soverini, Luana Bavaro, Caterina De Benedittis et al. · Blood · 2019 · 99 citations · Full text

Life Sciences, Genetics, Hematology +13

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP

Michele Baccarani, Elisabetta Abruzzese, Vincenzo Accurso et al. · Blood Advances · 2019 · 89 citations · Full text

Medicine, Hematology, Pharmacology +11

Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi

Francesco Merli, Stefano Luminari, Giuseppe Rossi et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2013 · 83 citations · Full text

Medicine, Geriatric Medicine, Oncology +17